J7200 Factor ix recombinan rixubis

Injection, factor ix, (antihemophilic factor, recombinant), rixubis, per iu

• Medicare coverage: Special coverage instructions apply
• Status: active (July 2026 file)
• MUE: max 20000 units per day (practitioner), rationale: Clinical: CMS Workgroup